Cleared Traditional

K123357 - ONQ RTS

K123357 is the FDA 510(k) clearance for ONQ RTS by Oncology Systems, Inc.. It is a Class 2 Radiology device (product code MUJ) cleared through the Traditional 510(k) pathway after a 58-day FDA review.

K123357 · Oncology Systems, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2012
Decision
58d
Days
Class 2
Risk

K123357 is an FDA 510(k) clearance for the ONQ RTS. Classified as System, Planning, Radiation Therapy Treatment (product code MUJ), Class II - Special Controls.

Submitted by Oncology Systems, Inc. (Shrewsbury, Shropshire, GB). The FDA issued a Cleared decision on December 28, 2012 after a review of 58 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Oncology Systems, Inc. devices

Submission Details

510(k) Number K123357 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 31, 2012
Decision Date December 28, 2012
Days to Decision 58 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
49d faster than avg
Panel avg: 107d · This submission: 58d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MUJ System, Planning, Radiation Therapy Treatment
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - MUJ System, Planning, Radiation Therapy Treatment

All 131
Devices cleared under the same product code (MUJ) and FDA review panel - the closest regulatory comparables to K123357.
ECLIPSE TREATMENT PLANNING SYSTEM
K133247 · Varian Medical Systems, Inc. · Feb 2014
4D INTEGRATED TREATMENT CONSOLE
K133331 · Varian Medical Systems, Inc. · Jan 2014
ECLIPSE TREATMENT PLANNING SYSTEM
K131891 · Varian Medical Systems, Inc. · Sep 2013
SYNGO RT INTERFACE
K120363 · Siemens Medical Solutions USA, Inc. · Mar 2012
IPLAN RT
K103246 · Brainlab AG · Mar 2011
LEKSELL GAMMAPLAN
K103093 · Elekta Instrument AB · Dec 2010